Bayer Diabetes Care Announces 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes to
Launch New CONTOUR(R) Meter
Win Chance to Meet Nick Jonas in Los Angeles and be Part of "Team Jonas" at
Diabetes Fundraiser
TARRYTOWN, N.Y., Aug. 25 /PRNewswire/ -- Bayer Diabetes Care and teen pop
sensation Nick Jonas of the Jonas Brothers invite people with diabetes to
enter the "Walk In Nick's Shoes" (W.I.N.S.) sweepstakes and four Grand Prize
winners will meet Nick Jonas in Los Angeles and have the opportunity to be
part of "Team Jonas" at the Juvenile Diabetes Research Foundation Walk for the
Cure in Los Angeles on November 1. The W.I.N.S. sweepstakes kicks off the
launch of Bayer's new CONTOUR(R) blood glucose meter. Earlier this month,
Bayer and Nick Jonas announced their partnership to provide young people and
their families with the motivation and support they need to help simplify life
with diabetes. The sweepstakes runs from Aug. 25-Oct. 1, 2008.
"It's going to be really exciting to meet the winners who will walk with other
young people and their families to raise awareness and funds for juvenile
diabetes," said Nick Jonas. "I'm lucky to have great support from my family,
friends and fans. By working with Bayer to help people see life in my shoes, I
hope that we can motivate others to better manage their diabetes."
Nick understands that so many of the approximately 150,000 of young adults
with type 1 and type 2 diabetes in the U.S. may feel embarrassed about their
condition, and he is striving to change that perception by sharing his own
story. Nick, diagnosed with type 1 diabetes at age 13, wants to inspire other
young people with diabetes to achieve Simple Wins: small, everyday victories
for managing the disease that can lead to big differences over time. For Nick
and his demanding schedule, that means using the CONTOUR(R) blood glucose
meter with new testing features that allow him to personalize it to match his
lifestyle.
"Every one of us who travel with Nick carry a CONTOUR(R) meter to make sure
we're there to support him whenever he needs it," said Denise Jonas, Nick's
mom. "The meters are easy for everyone to use, we can personalize their
features and they come in some great colors. Nick's personal favorite is
Pacific Blue."
Each of the Grand Prize winners of the "Walk In Nick's Shoes" (W.I.N.S.)
sweepstakes will receive a four-day/three-night trip to Los Angeles, CA for
the winner and one guest. The trip consists of round trip air transportation
to Los Angeles, standard hotel accommodations for three nights, ground
transportation and a daily allowance. Grand Prize winners will also receive a
Fit4D diabetes coaching program that includes a coach who will accompany the
winner during the walk, a one-to-one diabetes coaching package for four months
and eight months of fitness coaching. Additionally, ten First Prize winners
will receive a pair of sneakers autographed by Nick Jonas and 100 second prize
winners will receive a t-shirt. To enter the W.I.N.S. sweepstakes, log on to
www.NicksSimpleWins.com.
The new CONTOUR(R) meter is now available in four vibrant colors: Pacific
Blue, Royal Purple, Green Apple and Graphite Gray. The new CONTOUR(R) is the
only meter that offers patients the flexibility to choose, either, "Basic" or
"Advanced" levels of testing, to keep the management of their diabetes as
simple and specific as they would like. The new, personalized features include
programmable testing reminders and pre- and post-meal markers that provide
information on how a meal can affect blood glucose, a feature particularly
helpful for self-adjusting insulin users.
The sweepstakes is open to legal residents of the U.S. age 13 or older who
have been diagnosed with diabetes. Permission of parent (or legal guardian)
will be required for entrants under the age of 18. A random drawing will be
conducted on or about October 3, 2008 from among all eligible entries. Grand
Prize winners will be required to provide a letter from a physician confirming
winner's diagnosis of diabetes and stating that she or he is physically able
to participate in the Los Angeles JDRF Walk for the Cure. For the official
rules of the W.I.N.S. Sweepstakes, to learn more about Nick's personal
experiences and to read his blog about his latest activities, young people
with diabetes and their families can log on to www.NicksSimpleWins.com.
Bayer HealthCare, Diabetes Care
Bayer HealthCare, Diabetes Care is a worldwide leader in diabetes, supporting
customers in 100 countries. Since the introduction of CLINITEST(R) reagent
tablets in 1941, Bayer has led the way in diabetes care product innovation.
The company changed the face of diabetes care in 1969 when it introduced the
first portable blood glucose meter and test strips. Bayer HealthCare further
innovated diabetes management by being the first company to introduce a suite
of blood glucose monitors with No Coding(TM) technology. The BREEZE(R)2 and
CONTOUR(R) blood glucose monitoring systems offer people with diabetes an
unparalleled choice in diabetes management systems. The Arthritis
Foundation(R) in the United States and the Arthritis Society of Canada each
granted Ease-of-Use Commendation to the BREEZE(R)2 meter. BREEZE(R) represents
the first time a blood glucose meter has been recognized as easy to use for
arthritis sufferers.
In July 2006, Bayer Diabetes Care acquired Metrika Inc., maker and
manufacturer of A1CNow+, a meter-based diabetes monitoring system for
measurement of A1C (glycated hemoglobin) an important indicator of long term
blood sugar control.
Bayer HealthCare, Diabetes Care global headquarters is located in Tarrytown,
New York, in the United States and operates as part of Bayer HealthCare LLC, a
member of the worldwide Bayer HealthCare group. www.bayerdiabetes.com/us
Bayer HealthCare
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading,
innovative companies in the healthcare and medical products industry and is
based in Leverkusen, Germany. The company combines the global activities of
the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions.
The pharmaceuticals business operates under the name Bayer Schering Pharma AG.
Bayer HealthCare's aim is to discover and manufacture products that will
improve human and animal health worldwide.
This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. These
factors include those discussed in our public reports filed with the Frankfurt
Stock Exchange and with the U.S. Securities and Exchange Commission (including
our Form 20-F). The company assumes no liability whatsoever to update these
forward-looking statements or to inform them to future events or developments.
SOURCE Bayer Diabetes Care
Staci Gouveia, +1-914-366-1819, cell, +1-203-809-9008,
staci.gouveia.b@bayer.com, or Susan Yarin, +1-914-366-1738, cell,
+1-914-479-7589, susan.yarin.b@bayer.com, both of Bayer Diabetes Care
